Oral vs. intravenous Bisphosphonates

被引：0
|
作者：
Fahrleitner-Pammer, A. [1 ]
机构：
[1] Med Univ Klin Graz, Abt Endokrinol & Nuklearmed, Auenbruggerpl 15, A-8036 Graz, Austria
来源：
JOURNAL FUR MINERALSTOFFWECHSEL | 2009年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [31] Oral vs. intravenous (IV) lansoprazole are therapeutically equivalent in suppressing gastric acid secretion
    Freston, JW
    Kisicki, J
    Pilmer, BL
    Chiu, YL
    Vanden Boom, CM
    Stolle, JC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S51 - S52
  • [32] Association of Intravenous vs. Oral Iron Therapy with Risk of Infectious Outcomes in Patients with CKD
    Shrestha, Prabin
    Sumida, Keiichi
    Thomas, Fridtjof
    Surbhi, Satya
    Naser, Abu Mohd
    Streja, Elani
    Rhee, Connie
    Kalantar-Zadeh, Kamyar
    Kovesdy, Csaba P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [33] Intravenous vs. oral hydration administration for optimal ureteral opacification in computer tomographic urography
    Weatherspoon, Kimberly
    Smolinski, Sara
    Rakita, Dmitry
    Valdes, Carlos
    Garb, Jane
    Podsiadlo, Victoria
    Waslick, Maria
    Kreychman, Alena
    ABDOMINAL RADIOLOGY, 2017, 42 (12) : 2890 - 2897
  • [34] Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects
    Armstrong, D.
    James, C.
    Camacho, F.
    Chen, Y.
    Horbay, G. L. A.
    Teixeira, B.
    Husein-Bhabha, F. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (02) : 185 - 196
  • [35] Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia
    Spoorenberg, Simone M. C.
    Deneer, Vera H. M.
    Grutters, Jan C.
    Pulles, Astrid E.
    Voorn, G. P.
    Rijkers, Ger T.
    Bos, Willem Jan W.
    van de Garde, Ewoudt M. W.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (01) : 78 - 83
  • [36] Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy
    Aktaran, S.
    Akarsu, E.
    Erbagci, I.
    Araz, M.
    Okumus, S.
    Kartal, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (01) : 45 - 51
  • [37] COMPLIANCE AND EFFICACY IMPROVEMENT WITH GASTRORESISTANT FORMULATION OF WEEKLY ORAL RISEDRONATE VS. IMMEDIATE RELEASE ORAL BISPHOSPHONATES CAN BE ESTIMATED BY A SIMULATION MODEL
    Casado, E.
    Ortega, M.
    Sienes, V.
    Aristegui, I.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S472 - S473
  • [38] Intravenous bisphosphonates
    Hernández, JLH
    Moral, JAR
    Macías, JG
    MEDICINA CLINICA, 2005, 124 (09): : 348 - 354
  • [39] Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials (vol 19, 89, 2024)
    Li, Mingnian
    Ge, Zhuoqi
    Zhang, Benqi
    Sun, Li
    Wang, Zhongyuan
    Zou, Tao
    Chen, Qi
    ARCHIVES OF OSTEOPOROSIS, 2024, 19 (01)
  • [40] FLUOROURACIL - ORAL VS INTRAVENOUS ROUTE
    SHNIDER, BI
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 238 (10): : 1070 - 1070
12345